Back
Recursion Pharmaceuticals Vs. Docusign Industry Stock Comparison
Sell
49
RXRX
Recursion Pharmaceuticals
Last Price:
$5.36
Seasonality Move:
-5.87%
Sell
46
DOCU
Docusign
Last Price:
$77.95
Seasonality Move:
0.98%
Sell
49
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $5.27. The Score for RXRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Docusign (DOCU)
is a Sell
Is Docusign a Buy, Sell or Hold?
-
DOCU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $5.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight buying pressure.
DOCU Stock Price Chart
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 55.16 | Buy |
Chaikin Money Flow: | 5527369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.22 | Buy |
Relative Strength Index (14 RSI): | 47.68 | Sell |
Chaikin Money Flow: | 506557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.86 - 84.68) | Sell |
Bollinger Bands (100): | (76.24 - 87.54) | Sell |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.19 | Buy |
20-day SMA: | 5.13 | Buy |
50-day SMA: | 4.89 | Buy |
200-day SMA: | 6.3 | Sell |
8-day EMA: | 5.16 | Buy |
20-day EMA: | 5.06 | Buy |
50-day EMA: | 5.1 | Buy |
200-day EMA: | 6.21 | Sell |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.38 | Buy |
20-day SMA: | 76.32 | Buy |
50-day SMA: | 82.21 | Sell |
200-day SMA: | 81.21 | Sell |
8-day EMA: | 17.32 | Buy |
20-day EMA: | 7.42 | Buy |
50-day EMA: | 3.06 | Buy |
200-day EMA: | 0.78 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
Docusign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.05 per share, an increase this year of $0.66 per share, and an increase next year of $0.03 per share.
Recursion Pharmaceuticals Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Docusign Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |